Blood purificationHumansMaleFemaleMiddle AgedPeritoneal Dialysis
Effects of Daprodustat on Iron Metabolism in Peritoneal Dialysis Patients: An Exploratory Study.
Tomohiro Yan, Yukinao Sakai, Shunnosuke Kunoki, Akio Hirama, Tetsuya Kashiwagi, Masato Iwabu
Published: 202610.1159/000548832
Abstract
INTRODUCTION: Renal anemia is a serious complication in patients with chronic kidney disease. Daprodustat, a hypoxia-inducible factor-prolyl hydroxylase inhibitor, represents a potential therapeutic option for renal anemia; however, its efficacy and…
Preview only. Read the full abstract at the source